Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer

2009 ASCO Annual Meeting

29 May - 2 Jun 2009

Published: 3 Jul 2009

Views: 15934

Rating:

Save

Dr Gordon Rustin - Mount Vernon Cancer Center, UK

Gordon Rustin, MD, Mount Vernon Cancer Center, Hertfordshire, United Kingdom, speaking at ASCO 2009: Treatment Based on Rising CA125 Blood Levels Does Not Improve Survival for Recurrent Ovarian Cancer, Compared to Waiting for Symptoms to Arise: European researchers report that starting treatment early for an ovarian cancer relapse based on CA125 blood levels alone does not improve overall survival, compared with delaying treatment until symptoms arise.

Categories:
Ovary & gynaecology

Related Videos

Boosting HPV vaccination in India: A call to action

Ms Sutapa Biswas - Cancer Foundation of India, Kolkata, India

Boosting HPV vaccination in India: A call to action ( Ms Sutapa Biswas - Cancer Foundation of India, Kolkata, India )

Laser oncosurgery - A new perspective in treating cancer

Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India

Laser oncosurgery - A new perspective in treating cancer ( Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India )

WCI's role in the prevention of tobacco related cancer among Beedi rolling...

Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India

WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India ( Dr Surendran Veeraiah - Cancer Institute (WIA) Adyar, Chennai, India )

Alternative livelihood training programme for rural women who are employed in...

Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India

Alternative livelihood training programme for rural women who are employed in the tobacco industry in India ( Ms Sheeba Paul - Exodus Exports Pvt Ltd, Chennai, India )

Navigating cancer treatment choices

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India

Navigating cancer treatment choices ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )

Choosing Wisely in endometrial & cervix cancers: BMC data

Dr Indu Bansal - Paras Health, Gurgaon, India

Choosing Wisely in endometrial & cervix cancers: BMC data ( Dr Indu Bansal - Paras Health, Gurgaon, India )

Choosing Wisely in endometrial & cervix cancers: Surgery

Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India

Choosing Wisely in endometrial & cervix cancers: Surgery ( Dr Deepti Mishra - Tangham Cancer Center, Uttar Pradesh, India )

Choosing Wisely in endometrial & cervix cancers: Medical therapy

Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India

Choosing Wisely in endometrial & cervix cancers: Medical therapy ( Dr Jaya Ghosh - Tata Memorial Hospital, Mumbai, India )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer